Structure/function characterization of porcine CD59: Expression, chromosomal mapping, complement-inhibition and costimulatory activity

Transplantation

Volumn 66, Issue 8, 1998, Pages 1094-1100

  Maher, Stephen E ^a   Pflugh, David L ^a   Larsen, Niels J ^b   Rothschild, Max F ^b   Bothwell, Alfred L M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; GRAFT REJECTION; HUMAN; HUMAN CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD59; BASE SEQUENCE; CHO CELLS; CHROMOSOME MAPPING; COMPLEMENT SYSTEM PROTEINS; CRICETINAE; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; RNA; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE; T-LYMPHOCYTES;

EID: 0032573140     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810270-00021     Document Type: Article

References (33)

1. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261.
2. Davies A, Simmons DL, Hale G, et al. CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 1989; 170: 637.
3. Philbrick WM, Palfree RGE, Maher S, Bridgett MM, Sirlin S, Bothwell ALM. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur J Immunol 1990; 20: 87.
4. Motoyama N, Okada N, Yamashina M, Okada H. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur J Immunol 1992; 22: 2669.
5. Rollins SA, Sims PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990; 144: 3478.
6. van den Berg CW, Morgan BP. Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J Immunol 1994; 152: 4095.
7. Deckert M, Kubar J, Zoccola D, et al. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur J Immunol 1992; 22: 2943.
8. Hahn WC, Menu E, Bothwell ALM, Sims PJ, Bierer BE. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 1992; 256: 1805.
9. Menu E, Tsai BC, Bothwell ALM, Sims PJ, Bierer BE. CD59 costimulation of T cell activation: CD58-dependence and requirement for glycosylation. J Immunol 1994; 153: 2444.
10. Hamilton KK, Zhao J, Rollins S, Stewart BH, Sims PJ. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59. Blood 1990; 76: 2572.
11. Kaeffer B, Bottreau E, Marcon D, Olivier M, Lantier I, Salmon H. Histocompatible miniature pig (d/d haplotype): generation of hybridomas secreting A or M monoclonal antibody. Hybridoma 1991; 10: 731.
12. Khodadoust MK, Candal FJ, Maher SE, et al. PEC-A: an immortalized porcine aortic endothelial cell. Xenotransplant 1995; 2: 79.
13. Murray AG, Khodadoust MM, Pober JP, Bothwell ALM. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 11.
14. Zhou Q, Zhao J, Husler T, Sims PJ. Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function. Mol Immun 1996; 33: 1127.
15. Slanetz AE, Bothwell ALM. Heterodimeric, disulfide-linked αβ T cell receptors in solution. Eur J Immunol 1991; 21: 179.
16. Corr M, Slanetz AE, Boyd LF, et al. T cell receptor/MHC class I-peptide interaction: affinity, kinetics, and specificity. Science 1994; 265: 946.
17. Green P, Falls K, Crooks S. Documentation for CRI-MAP, version 2.4. 1990.
18. Mellink C, Lahbib-Mansais Y, Yerle M, Gellin J. PCR identification and physical localization of the genes for pig FSHB and LHB. Cytogenet Cell Genet 1995; 70: 224.
19. Rushmere NK, Harrison RA, van den Berg CW, Morgan BP. Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem J 1994; 304: 595.
20. Archibald AL, Haley CS, Brown JF, et al. The PiGMaP consortium linkage map of the domestic pig (Sus scrofa domestica). Mamm Genome 1995; 6: 157.
21. Zhao X-J, Zhao J, Zhou Q, Sims PJ. Identity of the residues responsible for the species restricted complement inhibitory function of human CD59. J Biol Chem 1998; 273: 10665.
22. Mouse Genome DataBase. Available at: http://www.informatics.jax.org/mgd.html. Accessed Nov. 27, 1997.
23. Petranka J, Zhao J, Norris J, et al. Structure-function relationships of the complement regulatory protein, CD59. Blood Cells Molecules Diseases 1996; 22: 281.
24. Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S. Mapping the active site of CD59. J Exp Med 1997; 185: 745.
25. Hinchliffe SJ, Rushmere NK, Hanna SM, Morgan BP. Molecular cloning and functional characterization of the pig analogue of CD59: relevance to xenotransplantation. J Immunol 1998; 160 3924.
26. Kennedy SP, Rollins SA, Burton WV, et al. Recombinant human CD59 protects porcine aortic endothelial cells from complement-mediated cell lysis and activation: strategy for prevention of hyperacute rejection in xenogeneic transplantation. Transplantation 1994; 57: 1494.
27. Kroshus TJ, Bolman RM III, Dalmasso AP, et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61: 1513.
28. Storck M, Abendroth D, Prestel R, et al. Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood. Transplantation 1997; 63: 304.
29. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complementmediated damage. Transplantation 1997; 63: 149.
30. Fodor WL, Rollins SA, Bianco-Caron S, et al. Primate terminal complement inhibitor homologues of human CD59. Immunogenetics 1995; 41: 51.
31. Powell MB, Marchbank KJ, Rushmere NK, van den Berg CW, Morgan BP. Molecular cloning, chromosomal location, expression, and functional characterization of the mouse analogue of human CD59. J Immunol 1997; 158: 1692.
32. Albrecht JC, Nicholas J, Cameron KR, Newman C, Fleckenstein B, Honess RW. Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 1992; 190; 527.
33. Genome DataBase. Available at: http://gdbwww.gdb.org/. Accessed Nov. 27, 1997.